Who is sponsoring NCT01613092?

NCT01613092 is sponsored by Population Health Research Institute.

What condition does NCT01613092 study?

NCT01613092 studies Arrhythmia.

What drugs are being tested in NCT01613092?

Interventions: Incremental, Cefazolin.

What is the status of NCT01613092?

NCT01613092 is currently COMPLETED.

Last reviewed 2014-10-09 · How we verify

Prevention of Arrhythmia Device Infection Trial (PADIT) Cluster Crossover Pilot Study

NCT01613092 Phase 4 COMPLETED

The goal of the pilot study is to compare whether a centre-wide policy of incremental antibiotic therapy will reduce pacemaker infection compared to a policy of conventional antibiotic prophylaxis in high-risk patients undergoing arrhythmia device procedures. This pilot study will provide feasibility information for a larger cluster randomized crossover design (CRCD).

Details

Lead sponsor	Population Health Research Institute
Phase	Phase 4
Status	COMPLETED
Enrolment	241
Start date	2011-05
Completion	2013-12

Conditions

Arrhythmia

Interventions

Incremental
Cefazolin

Primary outcomes

Hospitalization attributed to device infection — within one year of device procedure
Hospitalization attributed to device infection

Countries

Canada